(BCY) Barclays - Overview
Stock: Banking, Credit, Loans, Investments
| Risk 5d forecast | |
|---|---|
| Volatility | 32.3% |
| Relative Tail Risk | -1.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.26 |
| Alpha | 29.03 |
| Character TTM | |
|---|---|
| Beta | 1.172 |
| Beta Downside | 1.690 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.30% |
| CAGR/Max DD | 1.89 |
EPS (Earnings per Share)
Revenue
Description: BCY Barclays February 26, 2026
Barclays PLC (ticker BCY) is a UK-based diversified bank listed on XETRA, operating across retail, corporate, private, and investment banking segments in Europe, the Americas, Africa, the Middle East, and Asia.
The firm’s business lines include Barclays UK (retail and corporate banking), Barclays Private Bank & Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank, offering products such as current and savings accounts, mortgages, credit cards, unsecured loans, securities dealing, and investment management services.
In the most recent quarter (Q3 2025), Barclays reported total income of £7.5 billion, net profit of £2.1 billion, and a return on equity of 10.5%, while its Common Equity Tier 1 (CET1) capital ratio held at a robust 15.2%.
Key drivers for the sector include the European Central Bank’s policy rate staying near 4.0%, which supports net interest margins, and accelerating digital-banking adoption that is growing roughly 8% year-on-year across the bank’s retail channels.
For a deeper dive into Barclays’ valuation metrics, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 7.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.73 > 1.0 |
| NWC/Revenue: -729.3% < 20% (prev 842.1%; Δ -1571 % < -1%) |
| CFO/TA 0.01 > 3% & CFO 18.74b > Net Income 7.17b |
| Net Debt (-9.81b) to EBITDA (9.73b): -1.01 < 3 |
| Current Ratio: 0.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (13.88b) vs 12m ago -3.80% < -2% |
| Gross Margin: 45.42% > 18% (prev 0.98%; Δ 4444 % > 0.5%) |
| Asset Turnover: 2.60% > 50% (prev 1.64%; Δ 0.95% > 0%) |
| Interest Coverage Ratio: 0.45 > 6 (EBITDA TTM 9.73b / Interest Expense TTM 21.69b) |
Altman Z'' -1.02
| A: -0.19 (Total Current Assets 407.84b - Total Current Liabilities 697.65b) / Total Assets 1544.16b |
| B: 0.04 (Retained Earnings 59.25b / Total Assets 1544.16b) |
| C: 0.01 (EBIT TTM 9.73b / Avg Total Assets 1531.18b) |
| D: 0.04 (Book Value of Equity 62.72b / Total Liabilities 1445.72b) |
| Altman-Z'' Score: -1.02 = CCC |
Beneish M
| DSRI: none (Receivables 276.0m/none, Revenue 39.74b/24.96b) |
| GMI: 2.17 (GM 45.42% / 98.46%) |
| AQI: 0.85 (AQ_t 0.73 / AQ_t-1 0.86) |
| SGI: 1.59 (Revenue 39.74b / 24.96b) |
| TATA: -0.01 (NI 7.17b - CFO 18.74b) / TA 1544.16b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of BCY shares?
Over the past week, the price has changed by -2.42%, over one month by -1.57%, over three months by +16.94% and over the past year by +55.87%.
Is BCY a buy, sell or hold?
What are the forecasts/targets for the BCY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
BCY Fundamental Data Overview February 23, 2026
Market Cap GBP = 65.74b (75.44b EUR * 0.8715 EUR.GBP)
P/E Trailing = 11.1429
P/E Forward = 7.5245
P/S = 2.8129
P/B = 0.7114
P/EG = 1.32
Revenue TTM = 39.74b GBP
EBIT TTM = 9.73b GBP
EBITDA TTM = 9.73b GBP
Long Term Debt = unknown (none)
Short Term Debt = 35.40b GBP (from shortTermDebt, two quarters ago)
Debt = 219.94b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -9.81b GBP (from netDebt column, last quarter)
Enterprise Value = -121.88b GBP (65.74b + Debt 219.94b - CCE 407.56b)
Interest Coverage Ratio = 0.45 (Ebit TTM 9.73b / Interest Expense TTM 21.69b)
EV/FCF = -7.22x (Enterprise Value -121.88b / FCF TTM 16.88b)
FCF Yield = -13.85% (FCF TTM 16.88b / Enterprise Value -121.88b)
FCF Margin = 42.48% (FCF TTM 16.88b / Revenue TTM 39.74b)
Net Margin = 18.05% (Net Income TTM 7.17b / Revenue TTM 39.74b)
Gross Margin = 45.42% ((Revenue TTM 39.74b - Cost of Revenue TTM 21.69b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = -0.08 (set to none) (Enterprise Value -121.88b / Total Assets 1544.16b)
Interest Expense / Debt = 9.86% (Interest Expense 21.69b / Debt 219.94b)
Taxrate = 20.87% (388.0m / 1.86b)
NOPAT = 7.70b (EBIT 9.73b * (1 - 20.87%))
Current Ratio = 0.58 (Total Current Assets 407.84b / Total Current Liabilities 697.65b)
Debt / Equity = 2.83 (Debt 219.94b / totalStockholderEquity, last quarter 77.78b)
Debt / EBITDA = -1.01 (Net Debt -9.81b / EBITDA 9.73b)
Debt / FCF = -0.58 (Net Debt -9.81b / FCF TTM 16.88b)
Total Stockholder Equity = 76.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.47% (Net Income 7.17b / Total Assets 1544.16b)
RoE = 9.41% (Net Income TTM 7.17b / Total Stockholder Equity 76.24b)
RoCE = 1.15% (EBIT 9.73b / Capital Employed (Total Assets 1544.16b - Current Liab 697.65b))
RoIC = 3.53% (NOPAT 7.70b / Invested Capital 218.27b)
WACC = 8.36% (E(65.74b)/V(285.68b) * Re(10.24%) + D(219.94b)/V(285.68b) * Rd(9.86%) * (1-Tc(0.21)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.09%
[DCF] Terminal Value 68.58% ; FCFF base≈12.34b ; Y1≈8.10b ; Y5≈3.70b
[DCF] Fair Price = 5.64 (EV 67.95b - Net Debt -9.81b = Equity 77.76b / Shares 13.79b; r=8.36% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 42.80 | EPS CAGR: 91.10% | SUE: N/A | # QB: 0
Revenue Correlation: 43.30 | Revenue CAGR: 2.31% | SUE: 3.55 | # QB: 1